Characterisation of the Vasculature Within a Murine Adenocarcinoma Growing in Different Sites to Evaluate the Potential of Vascular Therapies
Open Access
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 34 (3) , 357-360
- https://doi.org/10.3109/02841869509093989
Abstract
Numerous vaso-active agents can affect vasculature in experimental solid tumours growing subcutaneously (s.c.), but these models are unlikely to reflect the vasculature of metastatic disease in man. The present study describes a murine orthotopic colon tumour which metastasises to the liver. Morphology and vascular pattern of caecal tumours is similar to s.c. tumours. Vascular occlusion caused by intravenous (i.v.) noradrenaline (NA) (160 μgkg−1) and hydralazine (HDZ) (10 mgkg−1) was 32% and 59% respectively for the caecal tumours compared with 35% and 78% for s.c. tumours. Significant morphological differences were seen between liver metastases and systemic deposits produced by i.v. inoculation of tumour cells. Liver metastases following orthotopic transplantation contained functional vasculature but no significant occlusion was seen with NA or HDZ. The vascular development and morphological appearance of secondary disease resulting from orthotopic implantation suggests that this would be a useful model for the study of agents that act either by vascular or anti-angiogenic mechanism.Keywords
This publication has 9 references indexed in Scilit:
- Potentiation of EO9 anti-tumour activity by hydralazineEuropean Journal Of Cancer, 1993
- The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumoursBritish Journal of Cancer, 1992
- Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in miceBritish Journal of Cancer, 1992
- Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512)Cancer Chemotherapy and Pharmacology, 1989
- Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazineBritish Journal of Cancer, 1988
- Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumoursBritish Journal of Cancer, 1988
- Brief Communication: Transplantation of Adenocarcinomas of the Colon in Mice 2JNCI Journal of the National Cancer Institute, 1975
- Anti-AngiogenesisAnnals of Surgery, 1972